This post was originally published on this site
Don’t miss these top money and investing features:
These money and investing stories, popular with MarketWatch readers over the past week, offer insight about how the stock market typically performs in December and give tips and advice about what you can do to stay on the upside of any year-end momentum.
Sign up here to get MarketWatch’s best mutual funds and ETF stories emailed to you weekly!
INVESTING NEWS & TRENDS
The Dow has completely recovered its 2020 bear-market loss. Here’s what comes next
Dow’s recovery since March is impressive but says nothing about how long the bull market will run, writes Mark Hulbert.
The Dow has completely recovered its 2020 bear-market loss. Here’s what comes next
The stock market is advancing without help from the FAAMNGs, which analysts say is a bullish sign
Market breadth suggests stocks have more room to rise in the months ahead.
The stock market is advancing without help from the FAAMNGs, which analysts say is a bullish sign
Momentum stocks may get an end-of-the-year push, history shows
Momentum stocks — those that have performed well in the past year — typically get a boost in December.
Momentum stocks may get an end-of-the-year push, history shows
This may be the perfect time to sell Tesla’s stock
Also, GM’s transformation, energy stocks and the dream retirement spot.
This may be the perfect time to sell Tesla’s stock
ETF Wrap: The long and short of it, and ETFs are assimilating mutual funds
ETF Wrap is a briefing of what investors need to know in the exchange-traded fund sector, including exclusive commentary and interviews on the industry from MarketWatch
ETF Wrap: The long and short of it, and ETFs are assimilating mutual funds
ETF Wrap: Holiday trading and free cash flow
ETF Wrap is a briefing of what investors need to know in the exchange-traded fund sector, including exclusive commentary and interviews on the industry from MarketWatch
ETF Wrap: Holiday trading and free cash flow
These drug distribution stocks have a built-in defense against Amazon Pharmacy
This market pro is holding McKesson, Cardinal Health and AmerisourceBergen in client portfolios.
These drug distribution stocks have a built-in defense against Amazon Pharmacy
Active managers see value in these 3 company practices but indexers hate them. Who’s right?
Savvy investors see value in combining CEO and chairman role, staggered director terms and dual share classes.
Active managers see value in these 3 company practices but indexers hate them. Who’s right?
The best money advice from these investment pros has nothing to do with stocks
“How I Invest My Money”: Good, practical advice and boilerplate prescriptions.
The best money advice from these investment pros has nothing to do with stocks
Should I rent or own property?
Owning a home has traditionally been considered part of the American dream, but is the investment always worth it? Here are the pros and cons of renting versus owning.
Should I rent or own property?
How to pick winners in the retail sector amid the pandemic
JJ Kinahan, Chief Market Strategist at TD Ameritrade, unpacks what investors are looking at in the retail sector as the holidays approach.
How to pick winners in the retail sector amid the pandemic
How to identify investing opportunities in disruptive technologies
Tesla, bitcoin, genomics and other investment opportunities driven by disruption. A conversation with Catherine Wood, CEO and founder of ARK Investment, from Investing in Tech: Diversified Disruption.
How to identify investing opportunities in disruptive technologies
